Clinical Trials on Interstitial Fibrosis
Total 6521 results
-
Norfolk and Norwich University Hospitals NHS Foundation...Norwich Clinical Trials UnitRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of British ColumbiaBoehringer IngelheimRecruitingIdiopathic Pulmonary FibrosisCanada
-
siRNAgen Therapeutics Inc.Active, not recruiting
-
University of Alabama at BirminghamCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisKorea, Republic of
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdActive, not recruitingIdiopathic Pulmonary FibrosisChina
-
Vanderbilt University Medical CenterTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Nils HoyerAarhus University Hospital; Nordic Bioscience A/SActive, not recruitingIdiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, Korea, Republic of, Belgium, Czechia, Australia, Germany, United Kingdom, United States, France, Finland, Japan, Poland, Hungary
-
Nitto Denko CorporationCompletedIdiopathic Pulmonary FibrosisUnited States, Germany, Japan, United Kingdom
-
University of PittsburghActive, not recruitingPulmonary FibrosisUnited States
-
Toray Industries, IncCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimActive, not recruiting
-
GRI Bio Operations, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States
-
Avalyn Pharma Inc.DevPro BiopharmaRecruitingProgressive Pulmonary FibrosisUnited States
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingIdiopathic Pulmonary Fibrosis
-
Shanghai Synvida Biotechnology Co.,Ltd.RecruitingIdiopathic Pulmonary FibrosisChina
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Beijing Tide Pharmaceutical Co., LtdNot yet recruitingIdiopathic Pulmonary Fibrosis
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingIdiopathic Pulmonary FibrosisChina
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, United Kingdom, New Zealand, Spain
-
Bridge Biotherapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of, Australia, Israel, Poland
-
Daewoong Pharmaceutical Co. LTD.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of
-
University Hospital, Gentofte, CopenhagenRecruiting
-
University of Alabama at BirminghamRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Manchester University NHS Foundation TrustRecruiting
-
Lawson Health Research InstituteRecruitingIdiopathic Pulmonary FibrosisCanada, Italy
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Novartis PharmaceuticalsActive, not recruitingIdiopathic Pulmonary FibrosisPoland, Germany, United States, Australia, Czechia, Argentina, Netherlands
-
Hoffmann-La RocheTerminatedIdiopathic Pulmonary FibrosisUnited States, France, Israel, Spain, Belgium, Australia, Czechia, Denmark, Taiwan, Italy, Japan, Singapore, Turkey, Korea, Republic of, Germany, China, New Zealand, Argentina, Portugal, South Africa, Hungary, Canada, Poland, Greece, Ne... and more
-
University of PittsburghJohns Hopkins University; Penn State University; Temple University; University...Active, not recruitingIdiopathic Pulmonary FibrosisUnited States
-
Vicore Pharma ABOrphan ReachCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, India, Ukraine, Russian Federation
-
Temple UniversityBoehringer IngelheimActive, not recruiting
-
CSL BehringCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, United Kingdom, Australia, Germany, Poland, Belgium, Austria, Denmark, Italy, Spain
-
Nils HoyerAarhus University HospitalActive, not recruiting
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
Guangzhou JOYO Pharma Co., LtdCompletedIdiopathic Pulmonary FibrosisChina
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Guy's and St Thomas' NHS Foundation TrustBoehringer IngelheimNot yet recruitingPulmonary Hypertension | Interstitial Lung Disease | Fibrosis LungUnited Kingdom
-
InSilico Medicine Hong Kong LimitedRecruitingStudy Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis (IPF)China
-
Guangdong Raynovent Biotech Co., LtdRecruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
University of ChicagoIdiopathic Pulmonary Fibrosis Clinical Research NetworkRecruitingIdiopathic Pulmonary Fibrosis | Sarcoidosis | Interstitial Lung Diseases | Connective Tissue DisorderUnited States
-
Redx Pharma PlcSimbec ResearchRecruitingFibrosis | IPFItaly, Spain, United States, Belgium, United Kingdom, Austria, Czechia, Poland, Switzerland
-
Istanbul Medipol University HospitalRecruiting
-
Pulmongene Ltd.Recruiting
-
Assistance Publique - Hôpitaux de ParisBoehringer IngelheimRecruitingSARS-Cov-2 Induced Pulmonary FibrosisFrance
-
Fondation Hôpital Saint-JosephRecruitingAcute Exacerbation of Idiopathic Pulmonary FibrosisFrance